Ventyx is now planning a larger, placebo-controlled Phase 2 trial in Parkinson’s, while also evaluating broader application in neurodegenerative conditions such as Alzheimer’s. https://longevity.technology/news/ventyx-touts-positive-results-in-parkinsons-trial/